FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017849767> ?p ?o ?g. }

• W2017849767 endingPage "24" @default.
• W2017849767 startingPage "19" @default.
• W2017849767 abstract "Ipragliflozin is a selective sodium glucose cotransporter 2 (SGLT2) inhibitor that increases urinary glucose excretion by inhibiting renal glucose reabsorption and thereby causes a subsequent antihyperglycemic effect. As nonalcoholic fatty liver disease (NAFLD), including nonalcoholic steatohepatitis (NASH), is closely linked to metabolic diseases such as obesity and diabetes, we investigated the effect of ipragliflozin on NAFLD in rats fed a choline-deficient l-amino acid-defined (CDAA) diet. Five weeks after starting the CDAA diet, rats exhibited hepatic triglyceride (TG) accumulation, fibrosis, and mild inflammation. Repeated oral administration of ipragliflozin (3mg/g, once daily for 5 weeks) prevented both hepatic TG accumulation (188 vs.290 mg/g tissue vehicle-treated group; P<0.001) and large lipid droplet formation. Further, ipragliflozin exerted a prophylactic effect on liver fibrosis, as indicated by a marked decrease in hydroxyproline content and fibrosis score. Pioglitazone, which is known to be effective on hepatic fibrosis in CDAA diet-fed rats as well as NASH patients with type 2 diabetes mellitus (T2DM), also exerted a mild prophylactic effect on fibrosis, but not on hepatic TG accumulation or inflammation. In conclusion, ipragliflozin prevented hepatic TG accumulation and fibrosis in CDAA-diet rats. These findings suggest the therapeutic potential of ipragliflozin for patients with NAFLD." @default.
• W2017849767 created "2016-06-24" @default.
• W2017849767 creator A5005442275 @default.
• W2017849767 creator A5010028041 @default.
• W2017849767 creator A5016629604 @default.
• W2017849767 creator A5016675904 @default.
• W2017849767 creator A5017481949 @default.
• W2017849767 creator A5039331241 @default.
• W2017849767 creator A5088760175 @default.
• W2017849767 date "2015-05-01" @default.
• W2017849767 modified "2023-10-17" @default.
• W2017849767 title "Ipragliflozin, an SGLT2 inhibitor, exhibits a prophylactic effect on hepatic steatosis and fibrosis induced by choline-deficient l-amino acid-defined diet in rats" @default.
• W2017849767 cites W11060070 @default.
• W2017849767 cites W1539079080 @default.
• W2017849767 cites W1580962701 @default.
• W2017849767 cites W1689732359 @default.
• W2017849767 cites W1967706329 @default.
• W2017849767 cites W1967749971 @default.
• W2017849767 cites W1974115114 @default.
• W2017849767 cites W1975654965 @default.
• W2017849767 cites W1981419458 @default.
• W2017849767 cites W1985527057 @default.
• W2017849767 cites W1995612841 @default.
• W2017849767 cites W2004221267 @default.
• W2017849767 cites W2015996457 @default.
• W2017849767 cites W2016103822 @default.
• W2017849767 cites W2019900066 @default.
• W2017849767 cites W2025657436 @default.
• W2017849767 cites W2029811522 @default.
• W2017849767 cites W2031054297 @default.
• W2017849767 cites W2053799987 @default.
• W2017849767 cites W2058484049 @default.
• W2017849767 cites W2059807848 @default.
• W2017849767 cites W2067740038 @default.
• W2017849767 cites W2072294025 @default.
• W2017849767 cites W2075224373 @default.
• W2017849767 cites W2087829753 @default.
• W2017849767 cites W2091486778 @default.
• W2017849767 cites W2092380707 @default.
• W2017849767 cites W2095574383 @default.
• W2017849767 cites W2103156933 @default.
• W2017849767 cites W2118881723 @default.
• W2017849767 cites W2120082515 @default.
• W2017849767 cites W2125946144 @default.
• W2017849767 cites W2125953431 @default.
• W2017849767 cites W2133469996 @default.
• W2017849767 cites W2151073893 @default.
• W2017849767 cites W2155481474 @default.
• W2017849767 cites W2157338541 @default.
• W2017849767 cites W2159773554 @default.
• W2017849767 cites W2163092618 @default.
• W2017849767 cites W2163207725 @default.
• W2017849767 doi "https://doi.org/10.1016/j.ejphar.2015.02.009" @default.
• W2017849767 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25701721" @default.
• W2017849767 hasPublicationYear "2015" @default.
• W2017849767 type Work @default.
• W2017849767 sameAs 2017849767 @default.
• W2017849767 citedByCount "90" @default.
• W2017849767 countsByYear W20178497672015 @default.
• W2017849767 countsByYear W20178497672016 @default.
• W2017849767 countsByYear W20178497672017 @default.
• W2017849767 countsByYear W20178497672018 @default.
• W2017849767 countsByYear W20178497672019 @default.
• W2017849767 countsByYear W20178497672020 @default.
• W2017849767 countsByYear W20178497672021 @default.
• W2017849767 countsByYear W20178497672022 @default.
• W2017849767 countsByYear W20178497672023 @default.
• W2017849767 crossrefType "journal-article" @default.
• W2017849767 hasAuthorship W2017849767A5005442275 @default.
• W2017849767 hasAuthorship W2017849767A5010028041 @default.
• W2017849767 hasAuthorship W2017849767A5016629604 @default.
• W2017849767 hasAuthorship W2017849767A5016675904 @default.
• W2017849767 hasAuthorship W2017849767A5017481949 @default.
• W2017849767 hasAuthorship W2017849767A5039331241 @default.
• W2017849767 hasAuthorship W2017849767A5088760175 @default.
• W2017849767 hasConcept C126322002 @default.
• W2017849767 hasConcept C134018914 @default.
• W2017849767 hasConcept C2776175330 @default.
• W2017849767 hasConcept C2776954865 @default.
• W2017849767 hasConcept C2777180221 @default.
• W2017849767 hasConcept C2778384471 @default.
• W2017849767 hasConcept C2778772119 @default.
• W2017849767 hasConcept C2779134260 @default.
• W2017849767 hasConcept C2779797417 @default.
• W2017849767 hasConcept C2780559512 @default.
• W2017849767 hasConcept C2993667909 @default.
• W2017849767 hasConcept C555293320 @default.
• W2017849767 hasConcept C71924100 @default.
• W2017849767 hasConcept C90466245 @default.
• W2017849767 hasConceptScore W2017849767C126322002 @default.
• W2017849767 hasConceptScore W2017849767C134018914 @default.
• W2017849767 hasConceptScore W2017849767C2776175330 @default.
• W2017849767 hasConceptScore W2017849767C2776954865 @default.
• W2017849767 hasConceptScore W2017849767C2777180221 @default.
• W2017849767 hasConceptScore W2017849767C2778384471 @default.
• W2017849767 hasConceptScore W2017849767C2778772119 @default.
• W2017849767 hasConceptScore W2017849767C2779134260 @default.
• W2017849767 hasConceptScore W2017849767C2779797417 @default.

• next